Easing the side effects of IL-2-LAK cell therapy.
D006801:Humans; D007376:Interleukin-2 / Q000009:adverse effects* / Q000627:therapeutic use; D015979:Killer Cells, Lymphokine-Activated / Q000637:transplantation*; D009369:Neoplasms / Q000628:therapy*
D007376:Interleukin-2